372 related articles for article (PubMed ID: 32522210)
1. Motivations, facilitators and barriers to accessing hepatitis C treatment among people who inject drugs in two South African cities.
Versfeld A; McBride A; Scheibe A; Spearman CW
Harm Reduct J; 2020 Jun; 17(1):39. PubMed ID: 32522210
[TBL] [Abstract][Full Text] [Related]
2. Understanding hepatitis B, hepatitis C and HIV among people who inject drugs in South Africa: findings from a three-city cross-sectional survey.
Scheibe A; Young K; Moses L; Basson RL; Versfeld A; Spearman CW; Sonderup MW; Prabdial-Sing N; Manamela J; Puren AJ; Rebe K; Hausler H
Harm Reduct J; 2019 Apr; 16(1):28. PubMed ID: 30975139
[TBL] [Abstract][Full Text] [Related]
3. HCV treatment access among Latinxs who inject drugs: qualitative findings from Boston, Massachusetts, 2016.
Mittal A; Kosinski KC; Stopka TJ
Harm Reduct J; 2019 Jul; 16(1):44. PubMed ID: 31288811
[TBL] [Abstract][Full Text] [Related]
4. "I want to feel young again": experiences and perspectives of young people who inject drugs living with hepatitis C in Vancouver, Canada.
Jacob J; Goodyear T; Coulaud PJ; Hoong P; Ti L; Knight R
Can J Public Health; 2021 Oct; 112(5):947-956. PubMed ID: 34115340
[TBL] [Abstract][Full Text] [Related]
5. "I want to get better, but…": identifying the perceptions and experiences of people who inject drugs with respect to evolving hepatitis C virus treatments.
Goodyear T; Brown H; Browne AJ; Hoong P; Ti L; Knight R
Int J Equity Health; 2021 Mar; 20(1):81. PubMed ID: 33740984
[TBL] [Abstract][Full Text] [Related]
6. Access to and acceptability of sexual and reproductive health, harm reduction and other essential health services among people who inject drugs in Durban, South Africa.
Milford C; Cavanagh T; Bosman S; Wilson M; Smit J; Zanoni B
Harm Reduct J; 2024 Jun; 21(1):123. PubMed ID: 38926755
[TBL] [Abstract][Full Text] [Related]
7. Barriers and motivators to participation and retention in HIV/HCV cohort studies among people who inject drugs: a community consultation in Iran.
Mirzazadeh A; Hosseini-Hooshyar S; Shahesmaeili A; Bahramnejad A; Barshan A; Mousavian G; Najafi E; Sharifi H; Haghdoost AA; Briceno A; McFarland W; Page K
Subst Abuse Treat Prev Policy; 2020 Aug; 15(1):56. PubMed ID: 32758246
[TBL] [Abstract][Full Text] [Related]
8. Barriers to access to hepatitis C treatment with direct-acting antivirals in people who inject drugs in the community setting.
Yela E; Solé N; Puig L; López Gallegos D; Clua-García R
Harm Reduct J; 2024 Apr; 21(1):88. PubMed ID: 38678266
[TBL] [Abstract][Full Text] [Related]
9. 'Treat my whole person, not just my condition': qualitative explorations of hepatitis C care delivery preferences among people who inject drugs.
Tsui JI; Barry MP; Austin EJ; Sweek EW; Tung E; Hansen RN; Ninburg M; Scott JD; Glick SN; Williams EC
Addict Sci Clin Pract; 2021 Aug; 16(1):52. PubMed ID: 34384494
[TBL] [Abstract][Full Text] [Related]
10. "Everybody living with a chronic disease is entitled to be cured": Challenges and opportunities in scaling up access to direct-acting antiviral hepatitis C virus treatment among people who inject drugs.
Goodyear T; Ti L; Carrieri P; Small W; Knight R
Int J Drug Policy; 2020 Jul; 81():102766. PubMed ID: 32416525
[TBL] [Abstract][Full Text] [Related]
11. Challenges and best practices for hepatitis C care among people who inject drugs in resource limited settings: focus group discussions with healthcare providers in Kenya.
Seu R; Riback LR; Nyakowa M; Lizcano J; Musyoki H; Ross J; Cherutich P; Kurth AE; Akiyama MJ
Glob Public Health; 2022 Dec; 17(12):3627-3637. PubMed ID: 35941717
[TBL] [Abstract][Full Text] [Related]
12. "Stigma is where the harm comes from": Exploring expectations and lived experiences of hepatitis C virus post-treatment trajectories among people who inject drugs.
Goodyear T; Brown H; Browne AJ; Hoong P; Ti L; Knight R
Int J Drug Policy; 2021 Oct; 96():103238. PubMed ID: 33902968
[TBL] [Abstract][Full Text] [Related]
13. Prevention, treatment and care of hepatitis C virus infection among people who inject drugs.
Bruggmann P; Grebely J
Int J Drug Policy; 2015 Feb; 26 Suppl 1():S22-6. PubMed ID: 25245939
[TBL] [Abstract][Full Text] [Related]
14. Evidence-based and guideline-concurrent responses to narratives deferring HCV treatment among people who inject drugs.
Childs E; Assoumou SA; Biello KB; Biancarelli DL; Drainoni ML; Edeza A; Salhaney P; Mimiaga MJ; Bazzi AR
Harm Reduct J; 2019 Feb; 16(1):14. PubMed ID: 30744628
[TBL] [Abstract][Full Text] [Related]
15. A simplified point-of-service model for hepatitis C in people who inject drugs in South Africa.
Saayman E; Hechter V; Kayuni N; Sonderup MW
Harm Reduct J; 2023 Mar; 20(1):27. PubMed ID: 36870990
[TBL] [Abstract][Full Text] [Related]
16. Perceptions of network based recruitment for hepatitis C testing and treatment among persons who inject drugs: a qualitative exploration.
Ward KM; McCormick SD; Sulkowski M; Latkin C; Chander G; Falade-Nwulia O
Int J Drug Policy; 2021 Feb; 88():103019. PubMed ID: 33160152
[TBL] [Abstract][Full Text] [Related]
17. Improving access to care for people who inject drugs: Qualitative evaluation of project ITTREAT-An integrated community hepatitis C service.
Phillips C; Schulkind J; O'Sullivan M; Edelman N; Smith HE; Verma S; Jones CJ
J Viral Hepat; 2020 Feb; 27(2):176-187. PubMed ID: 31566851
[TBL] [Abstract][Full Text] [Related]
18. Barriers and facilitators of hepatitis C treatment uptake among people who inject drugs enrolled in opioid treatment programs in Baltimore.
Falade-Nwulia O; Irvin R; Merkow A; Sulkowski M; Niculescu A; Olsen Y; Stoller K; Thomas DL; Latkin C; Mehta SH
J Subst Abuse Treat; 2019 May; 100():45-51. PubMed ID: 30898327
[TBL] [Abstract][Full Text] [Related]
19. Priorities and recommended actions for how researchers, practitioners, policy makers, and the affected community can work together to improve access to hepatitis C care for people who use drugs.
Day E; Broder T; Bruneau J; Cruse S; Dickie M; Fish S; Grillon C; Luhmann N; Mason K; McLean E; Trooskin S; Treloar C; Grebely J
Int J Drug Policy; 2019 Apr; 66():87-93. PubMed ID: 30743093
[TBL] [Abstract][Full Text] [Related]
20. Values and preferences for hepatitis C self-testing among people who inject drugs in Kyrgyzstan.
Martínez-Pérez GZ; Nikitin DS; Bessonova A; Fajardo E; Bessonov S; Shilton S
BMC Infect Dis; 2021 Jun; 21(1):609. PubMed ID: 34171990
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
